Market

Syngene’s EBITDA margin will also moderate from current levels, according to the management to mid-twenties, due to incremental operating expenses from the new plant. Source

Indian pharma stocks drop as Trump plans to cut drug prices, impacting companies reliant on U.S. market. Source

Nestle, Hindustan Unilever, ITC and Tata Consultancy Services were among the laggards. Source

Sensex and Nifty surge nearly 4% as India-Pakistan tensions ease and U.S.-China tariffs lower, marking biggest gains. Source

Persistent Systems reported constant currency revenue growth of 4.5% for the March quarter, which is higher compared to street estimates, which ranged between 3.7% and 3.8%. Revenue growth in constant currency terms stood at 4.6% in the previous quarter and 3.4% during the same quarter last year.  Source

Rupee strengthens against US dollar on easing tensions, foreign investor interest, and positive trade agreements, impacting forex market. Source

Divi’s Laboratories has a high potential to become a primary supplier given its capacity addition, Citi said in its note, further adding that Orforglipron, Eli Lilly’s potential best-in-class oral GLP-1, is the next addition in Divi’s Laboratories’ pipeline. Source

Equity indices Sensex and Nifty drop after sharp rally, driven by profit-taking, while global markets show positive trends. Source

The Nifty 50 fell 0.56 per cent to 23,184.8 points as of 9:20 a.m. IST, while the BSE Sensex shed 0.55 per cent to 76,616.5. Source

Zepto sees increase in Indian ownership with $100M deal, aiming for 50% threshold before IPO. Source